Patents Assigned to SGN Nanopharma Inc
  • Patent number: 11311477
    Abstract: The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: April 26, 2022
    Assignee: SGN NANOPHARMA INC.
    Inventors: Robert Lee, Dinesh Shenoy
  • Patent number: 11173112
    Abstract: The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: November 16, 2021
    Assignee: SGN NANOPHARMA INC.
    Inventors: Robert Lee, Dinesh Shenoy
  • Publication number: 20190076354
    Abstract: The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.
    Type: Application
    Filed: November 7, 2018
    Publication date: March 14, 2019
    Applicant: SGN Nanopharma Inc.
    Inventors: Robert Lee, Dinesh Shenoy
  • Publication number: 20190070106
    Abstract: The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.
    Type: Application
    Filed: November 7, 2018
    Publication date: March 7, 2019
    Applicant: SGN Nanopharma Inc.
    Inventors: Robert Lee, Dinesh Shenoy
  • Patent number: 10137083
    Abstract: The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.
    Type: Grant
    Filed: January 16, 2008
    Date of Patent: November 27, 2018
    Assignee: SGN Nanopharma Inc
    Inventors: Robert Lee, Dinesh Shenoy